List of Tables
Table 1. Major Company of Dopamine Agonist
Table 2. Major Company of Monoamine Oxidase Inhibitors
Table 3. Major Company of Acetylcholinesterase Inhibitors
Table 4. Major Company of Glutamate Inhibitors
Table 5. Global Parkinson's Disease (PD) Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (K Pcs)
Table 7. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type (2018-2023)
Table 8. Global Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (US& Million)
Table 9. Global Parkinson's Disease (PD) Drugs Market Share in Value by Type (2018-2023)
Table 10. Global Parkinson's Disease (PD) Drugs Price by Type (2018-2023) & (USD/Pcs)
Table 11. Global Parkinson's Disease (PD) Drugs Sales by Type (2024-2029) & (K Pcs)
Table 12. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Parkinson's Disease (PD) Drugs Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type (2024-2029)
Table 15. Global Parkinson's Disease (PD) Drugs Price by Type (2024-2029) & (USD/Pcs)
Table 16. North America Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (K Pcs)
Table 17. North America Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (US$ Million)
Table 18. Europe Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2018-2023)
Table 19. Europe Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (US$ Million)
Table 20. Asia-Pacific Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2018-2023)
Table 21. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (US$ Million)
Table 22. Latin America Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2018-2023)
Table 23. Latin America Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (US$ Million)
Table 24. Middle East and Africa Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2018-2023)
Table 25. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Type (2018-2023) & (US$ Million)
Table 26. Global Parkinson's Disease (PD) Drugs Sales by Company (2018-2023) & (K Pcs)
Table 27. Global Parkinson's Disease (PD) Drugs Sales Share by Company (2018-2023)
Table 28. Global Parkinson's Disease (PD) Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 29. Global Parkinson's Disease (PD) Drugs Revenue Share by Company (2018-2023)
Table 30. Global Market Parkinson's Disease (PD) Drugs Price by Company (2018-2023) & (USD/Pcs)
Table 31. Global Parkinson's Disease (PD) Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2022)
Table 34. Date of Key Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
Table 35. Key Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Parkinson's Disease (PD) Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Parkinson's Disease (PD) Drugs Sales by Region (2018-2023) & (K Pcs)
Table 39. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Region (2018-2023)
Table 40. Global Parkinson's Disease (PD) Drugs Sales by Region (2018-2023) & (US$ Million)
Table 41. Global Parkinson's Disease (PD) Drugs Sales Market Share in Value by Region (2018-2023)
Table 42. Global Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 43. Global Parkinson's Disease (PD) Drugs Sales by Region (2024-2029) & (K Pcs)
Table 44. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Parkinson's Disease (PD) Drugs Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Parkinson's Disease (PD) Drugs Sales Market Share in Value by Region (2024-2029)
Table 47. Global Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2029)
Table 48. Global Parkinson's Disease (PD) Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) & (K Pcs)
Table 50. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application (2018-2023)
Table 51. Global Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) & (US$ Million)
Table 52. Global Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application (2018-2023)
Table 53. Global Parkinson's Disease (PD) Drugs Price by Application (2018-2023) & (USD/Pcs)
Table 54. Global Parkinson's Disease (PD) Drugs Sales by Application (2024-2029) & (K Pcs)
Table 55. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Parkinson's Disease (PD) Drugs Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application (2024-2029)
Table 58. Global Parkinson's Disease (PD) Drugs Price by Application (2024-2029) & (USD/Pcs)
Table 59. North America Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) (K Pcs)
Table 60. North America Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) & (US$ Million)
Table 61. Europe Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) (K Pcs)
Table 62. Europe Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) & (US$ Million)
Table 63. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) (K Pcs)
Table 64. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) & (US$ Million)
Table 65. Latin America Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) (K Pcs)
Table 66. Latin America Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) & (US$ Million)
Table 67. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) (K Pcs)
Table 68. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Application (2018-2023) & (US$ Million)
Table 69. North America Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (K Pcs)
Table 70. North America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2018-2023)
Table 71. North America Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (US$ Million)
Table 72. North America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2018-2023)
Table 73. North America Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (K Pcs)
Table 74. North America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (K Pcs)
Table 78. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2018-2023)
Table 79. Europe Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (US$ Million)
Table 80. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2018-2023)
Table 81. Europe Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (K Pcs)
Table 82. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Region (2018-2023) & (K Pcs)
Table 86. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Region (2018-2023)
Table 87. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Region (2018-2023) & (US$ Million)
Table 88. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Value by Region (2018-2023)
Table 89. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Region (2024-2029) & (K Pcs)
Table 90. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (K Pcs)
Table 94. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2018-2023)
Table 95. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (US$ Million)
Table 96. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2018-2023)
Table 97. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (K Pcs)
Table 98. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (K Pcs)
Table 102. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2018-2023)
Table 103. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2018-2023) & (US$ Million)
Table 104. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2018-2023)
Table 105. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (K Pcs)
Table 106. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share in Value by Country (2024-2029)
Table 109. Boehringer Ingelheim Company Information
Table 110. Boehringer Ingelheim Introduction and Business Overview
Table 111. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 112. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product
Table 113. Boehringer Ingelheim Recent Development
Table 114. GlaxoSmithKline Company Information
Table 115. GlaxoSmithKline Introduction and Business Overview
Table 116. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 117. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product
Table 118. GlaxoSmithKline Recent Development
Table 119. Novartis Company Information
Table 120. Novartis Introduction and Business Overview
Table 121. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 122. Novartis Parkinson's Disease (PD) Drugs Product
Table 123. Novartis Recent Development
Table 124. Teva Pharmaceutical Industries Company Information
Table 125. Teva Pharmaceutical Industries Introduction and Business Overview
Table 126. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 127. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product
Table 128. Teva Pharmaceutical Industries Recent Development
Table 129. AbbVie Company Information
Table 130. AbbVie Introduction and Business Overview
Table 131. AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 132. AbbVie Parkinson's Disease (PD) Drugs Product
Table 133. AbbVie Recent Development
Table 134. Abital Pharma Company Information
Table 135. Abital Pharma Introduction and Business Overview
Table 136. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 137. Abital Pharma Parkinson's Disease (PD) Drugs Product
Table 138. Abital Pharma Recent Development
Table 139. Addex Therapeutics Company Information
Table 140. Addex Therapeutics Introduction and Business Overview
Table 141. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 142. Addex Therapeutics Parkinson's Disease (PD) Drugs Product
Table 143. Addex Therapeutics Recent Development
Table 144. Biogen Company Information
Table 145. Biogen Introduction and Business Overview
Table 146. Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 147. Biogen Parkinson's Disease (PD) Drugs Product
Table 148. Biogen Recent Development
Table 149. Eisai Company Information
Table 150. Eisai Introduction and Business Overview
Table 151. Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 152. Eisai Parkinson's Disease (PD) Drugs Product
Table 153. Eisai Recent Development
Table 154. Eli Lilly Company Information
Table 155. Eli Lilly Introduction and Business Overview
Table 156. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 157. Eli Lilly Parkinson's Disease (PD) Drugs Product
Table 158. Eli Lilly Recent Development
Table 159. F. Hoffmann-La Roche Company Information
Table 160. F. Hoffmann-La Roche Introduction and Business Overview
Table 161. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 162. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product
Table 163. F. Hoffmann-La Roche Recent Development
Table 164. H. Lundbeck Company Information
Table 165. H. Lundbeck Introduction and Business Overview
Table 166. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 167. H. Lundbeck Parkinson's Disease (PD) Drugs Product
Table 168. H. Lundbeck Recent Development
Table 169. Impax Laboratories Company Information
Table 170. Impax Laboratories Introduction and Business Overview
Table 171. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 172. Impax Laboratories Parkinson's Disease (PD) Drugs Product
Table 173. Impax Laboratories Recent Development
Table 174. Kyowa Hakko Kirin Company Information
Table 175. Kyowa Hakko Kirin Introduction and Business Overview
Table 176. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 177. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product
Table 178. Kyowa Hakko Kirin Recent Development
Table 179. Otsuka Pharmaceutical Company Information
Table 180. Otsuka Pharmaceutical Introduction and Business Overview
Table 181. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 182. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product
Table 183. Otsuka Pharmaceutical Recent Development
Table 184. Pfizer Company Information
Table 185. Pfizer Introduction and Business Overview
Table 186. Pfizer Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 187. Pfizer Parkinson's Disease (PD) Drugs Product
Table 188. Pfizer Recent Development
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. Parkinson's Disease (PD) Drugs Market Trends
Table 192. Parkinson's Disease (PD) Drugs Market Drivers
Table 193. Parkinson's Disease (PD) Drugs Market Challenges
Table 194. Parkinson's Disease (PD) Drugs Market Restraints
Table 195. Parkinson's Disease (PD) Drugs Distributors List
Table 196. Parkinson's Disease (PD) Drugs Downstream Customers
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Parkinson's Disease (PD) Drugs Product Picture
Figure 2. Global Parkinson's Disease (PD) Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Parkinson's Disease (PD) Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Parkinson's Disease (PD) Drugs Sales Status and Outlook (2018-2029) & (K Pcs)
Figure 5. Product Picture of Dopamine Agonist
Figure 6. Global Dopamine Agonist Sales YoY Growth (2018-2029) & (K Pcs)
Figure 7. Product Picture of Monoamine Oxidase Inhibitors
Figure 8. Global Monoamine Oxidase Inhibitors Sales YoY Growth (2018-2029) & (K Pcs)
Figure 9. Product Picture of Acetylcholinesterase Inhibitors
Figure 10. Global Acetylcholinesterase Inhibitors Sales YoY Growth (2018-2029) & (K Pcs)
Figure 11. Product Picture of Glutamate Inhibitors
Figure 12. Global Glutamate Inhibitors Sales YoY Growth (2018-2029) & (K Pcs)
Figure 13. Global Parkinson's Disease (PD) Drugs Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2022 & 2029
Figure 15. North America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type in 2022
Figure 16. North America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type in 2022
Figure 17. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type in 2022
Figure 21. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Parkinson's Disease (PD) Drugs Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Parkinson's Disease (PD) Drugs Revenue in 2022
Figure 27. Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2029) & (K Pcs)
Figure 30. Product Picture of Family
Figure 31. Global Family Sales YoY Growth (2018-2029) & (K Pcs)
Figure 32. Global Parkinson's Disease (PD) Drugs Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2022 & 2029
Figure 34. North America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application in 2022
Figure 35. North America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application in 2022
Figure 36. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Europe Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application in 2022
Figure 40. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Parkinson's Disease (PD) Drugs Manufacturing Cost Structure
Figure 45. Parkinson's Disease (PD) Drugs Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed